2000
Breast Cancer Risk Associated with Congeners of Polychlorinated Biphenyls
Zheng T, Holford TR, Tessari J, Mayne ST, Owens PH, Ward B, Carter D, Boyle P, Dubrow R, Archibeque-Engle S, Zahm SH. Breast Cancer Risk Associated with Congeners of Polychlorinated Biphenyls. American Journal Of Epidemiology 2000, 152: 50-58. PMID: 10901329, DOI: 10.1093/aje/152.1.50.Peer-Reviewed Original ResearchConceptsBreast cancer riskCancer riskCovariate-adjusted odds ratioBreast Cancer Risk AssociatedCase-control studyBreast cancer casesBreast adipose tissueMean tissue levelsCancer Risk AssociatedLowest tertileThird tertileBreast diseaseOdds ratioBreast cancerCancer casesConnecticut womenAdipose tissueFurther stratificationSignificant associationStudy participantsTissue levelsNonhormonal activitiesBody levelEnvironmental exposuresSpecific PCB congeners
1999
β‐Benzene hexachloride in breast adipose tissue and risk of breast carcinoma
Zheng T, Holford T, Mayne S, Owens P, Ward B, Carter D, Dubrow R, Zahm S, Boyle P, Tessari J. β‐Benzene hexachloride in breast adipose tissue and risk of breast carcinoma. Cancer 1999, 85: 2212-2218. PMID: 10326700, DOI: 10.1002/(sici)1097-0142(19990515)85:10<2212::aid-cncr16>3.0.co;2-f.Peer-Reviewed Original ResearchConceptsBreast adipose tissueAdipose tissue levelsBreast carcinoma riskBreast carcinoma casesBreast carcinomaAdipose tissueCarcinoma casesCarcinoma riskTissue levelsBenign breast diseaseProgesterone receptor statusPatients age 40Association of exposurePrimary breast carcinomaLogistic regression modelsPostmenopausal womenMenopausal statusParous womenNulliparous womenReceptor statusHighest quartilePotential confoundersBreast diseaseΒ-benzene hexachlorideConnecticut women
1985
Risk Factors for Fibrocystic Breast Disease and Its Histopathologic Components2
Berkowitz G, Kelsey J, LiVolsi V, Holford T, Merino M, Ort S, O'Connor T, White C. Risk Factors for Fibrocystic Breast Disease and Its Histopathologic Components2. Journal Of The National Cancer Institute 1985, 75: 43-50. PMID: 3859695, DOI: 10.1093/jnci/75.1.43.Peer-Reviewed Original ResearchConceptsFibrocystic breast diseaseBenign breast diseaseBreast diseaseHigher socioeconomic statusOdds ratioLow Quetelet's indexSocioeconomic statusBreast cancer patientsCase-control studyEpidemiologic similaritiesCurrent smokersPostmenopausal womenPremenopausal womenEpithelial atypiaGross cystsFibrocystic diseaseCancer patientsPapillary hyperplasiaQuetelet indexBiopsy specimensRisk factorsSurgical conditionsConnecticut hospitalsLow parityBreast cancerAN EPIDEMIOLOGIC STUDY OF FIBROCYSTIC BREAST DISEASE WITH REFERENCE TO DUCTAL EPITHELIAL ATYPIA
PASTIDES H, KELSEY J, HOLFORD T, LIVOLSI V. AN EPIDEMIOLOGIC STUDY OF FIBROCYSTIC BREAST DISEASE WITH REFERENCE TO DUCTAL EPITHELIAL ATYPIA. American Journal Of Epidemiology 1985, 121: 440-447. PMID: 4014134, DOI: 10.1093/oxfordjournals.aje.a114016.Peer-Reviewed Original ResearchConceptsFibrocystic breast diseaseDuctal epithelial atypiaCase-control studyBreast diseaseDuctal atypiaEpithelial atypiaMinimal atypiaBreast cancerFirst-degree female relativesBreast biopsy specimensRecent checkupSurgical menopauseEpidemiologic characteristicsFirst pregnancyBiopsy specimensRisk factorsEpidemiologic studiesAtypiaCheckupAtypia scoreFrequent checkupsBreast lesionsDiseaseFemale relativesOnly variableESTROGEN REPLACEMENT THERAPY AND FIBROCYSTIC BREAST DISEASE IN POSTMENOPAUSAL WOMEN1
BERKOWITZ G, KELSEY J, HOLFORD T, LIVOLSI V, MERINO M, BECK G, ORT S, O'CONNOR T, WHITE C. ESTROGEN REPLACEMENT THERAPY AND FIBROCYSTIC BREAST DISEASE IN POSTMENOPAUSAL WOMEN1. American Journal Of Epidemiology 1985, 121: 238-245. PMID: 4014118, DOI: 10.1093/oxfordjournals.aje.a113994.Peer-Reviewed Original ResearchConceptsFibrocystic breast diseaseEstrogen replacement therapyBreast diseaseReplacement therapyPostmenopausal womenHospital-based case-control studyMedical care utilizationPossible risk factorsCase-control studyDuration of useOdds of diseasePostmenopausal women1Care utilizationMenopausal estrogensExcess oddsRisk factorsSurgical conditionsTherapyDiseasePositive associationMore yearsWomenOddsAssociationEstrogen
1984
Exogenous hormone use and fibrocystic breast disease by histopathologic component
Berkowitz G, Kelsey J, Livolsi V, Merino M, Holford T, Hildreth N, Ort S, O'Connor T, White C. Exogenous hormone use and fibrocystic breast disease by histopathologic component. International Journal Of Cancer 1984, 34: 443-449. PMID: 6490201, DOI: 10.1002/ijc.2910340403.Peer-Reviewed Original ResearchConceptsFibrocystic breast diseaseEstrogen replacement therapyBreast diseaseGross cystsReplacement therapyHospital-based case-control studyExogenous hormone useOral contraceptive usePost-menopausal womenCase-control studyPostmenopausal womenPremenopausal womenHormone useOral contraceptivesEpithelial atypiaControl womenPapillary hyperplasiaBiopsy specimensFibrocystic lesionsSurgical conditionsContraceptive useHistopathologic componentsWomenIncreased occurrenceDiseaseORAL CONTRACEPTIVE USE AND FIBROCYSTIC BREAST DISEASE AMONG PRE- AND POSTMENOPAUSAL WOMEN1
BERKOWITZ G, KELSEY J, LIVOLSI V, HOLFORD T, MERINO M, ORT S, O'CONNOR T, GOLDENBERG I, WHITE C. ORAL CONTRACEPTIVE USE AND FIBROCYSTIC BREAST DISEASE AMONG PRE- AND POSTMENOPAUSAL WOMEN1. American Journal Of Epidemiology 1984, 120: 87-96. PMID: 6741927, DOI: 10.1093/oxfordjournals.aje.a113878.Peer-Reviewed Original ResearchConceptsFibrocystic breast diseaseOral contraceptive useBreast diseaseOral contraceptivesContraceptive useHospital-based case-control studyOral contraceptive exposureGeneral surgical serviceCase-control studyLong-term useContraceptive exposurePostmenopausal women1Postmenopausal womenPremenopausal womenCystic diseaseStudy groupSurgical servicesDecreased frequencyPast usersDiseaseIncreased occurrenceWomenContraceptivesNegative associationAssociation
1983
Oral Contraceptive Use and Fibrocystic Breast Disease With Special Reference to Its Histopathology23
Pastides H, Kelsey J, LiVolsi V, Holford T, Fischer D, Goldenberg I. Oral Contraceptive Use and Fibrocystic Breast Disease With Special Reference to Its Histopathology23. Journal Of The National Cancer Institute 1983, 71: 5-9. PMID: 6575209, DOI: 10.1093/jnci/71.1.5.Peer-Reviewed Original ResearchConceptsOral contraceptive useFibrocystic breast diseaseOral contraceptivesContraceptive useBiopsy specimensBreast diseaseHospital-based case-control studyCase-control studyHigh atypiaEpithelial atypiaGross cystsHistopathologic characteristicsFibrocystic diseaseAtypiaContraceptivesDiseaseMicroscopic cystsCystsNew HavenSimilar patternPapillomatosisHistopathologySpecial referenceCasesControl
1982
Effect of age at first childbirth on risk of developing specific histologic subtype of breast cancer
Livolsi V, Kelsey J, Fischer D, Holford T, Mostow E, Goldenberg I. Effect of age at first childbirth on risk of developing specific histologic subtype of breast cancer. Cancer 1982, 49: 1937-1940. PMID: 6280850, DOI: 10.1002/1097-0142(19820501)49:9<1937::aid-cncr2820490931>3.0.co;2-h.Peer-Reviewed Original ResearchConceptsBreast cancerRisk factorsHistologic subtypeLobular carcinomaSpecific histologic subtypesBenign breast diseaseBreast cancer riskCase-control studyFirst childLater ageVariety of cancersPostmenopausal womenDuct cancerEffect of ageNulliparous womenDuctal carcinomaHistopathologic subtypeEpidemiologic variablesLobular tumorsBreast diseaseBreast carcinomaFamily historyCancer riskBody weightComparison women
1979
Fibroadenoma in oral contraceptive users. A histopathologic evaluation of epithelial atypia
Livolsi V, Stadel B, Kelsey J, Holford T. Fibroadenoma in oral contraceptive users. A histopathologic evaluation of epithelial atypia. Cancer 1979, 44: 1778-1781. PMID: 498048, DOI: 10.1002/1097-0142(197911)44:5<1778::aid-cncr2820440535>3.0.co;2-y.Peer-Reviewed Original ResearchConceptsEpithelial atypiaLong-term usersOral contraceptivesOral contraceptive useOral contraceptive usersFibrocystic diseaseHistopathologic evaluationBreast diseaseContraceptive usersCytologic atypiaContraceptive useEpithelial componentAtypiaEpidemiological investigationsFibroadenomaDiseaseContraceptives
1978
Fibrocystic Breast Disease in Oral-Contraceptive Users — A Histopathological Evaluation of Epithelial Atypia
Livolsi V, Stadel B, Kelsey J, Holford T, White C. Fibrocystic Breast Disease in Oral-Contraceptive Users — A Histopathological Evaluation of Epithelial Atypia. New England Journal Of Medicine 1978, 299: 381-385. PMID: 566853, DOI: 10.1056/nejm197808242990803.Peer-Reviewed Original ResearchConceptsFibrocystic breast diseaseOral contraceptivesLong-term usersBreast cancerEpithelial atypiaFibrocystic diseaseBreast diseaseOral contraceptive usersLong-term usePremenopausal womenHistopathological evaluationHistologic standpointCystic diseasePremalignant formsEpidemiological studiesDiseaseContraceptivesAtypiaCancerWomenSignificant differencesNontakersIncidenceORAL CONTRACEPTIVES AND BREAST DISEASE
KELSEY J, HOLFORD T, WHITE C, MAYER E, KILTY S, ACHESON R. ORAL CONTRACEPTIVES AND BREAST DISEASE. American Journal Of Epidemiology 1978, 107: 236-244. PMID: 629261, DOI: 10.1093/oxfordjournals.aje.a112530.Peer-Reviewed Original ResearchConceptsBenign breast diseaseOral contraceptivesBreast diseaseSequential oral contraceptivesCombination oral contraceptivesAge group 20Case-control studyCorpus uteriRelative riskBreast cancerGroup 20ContraceptivesNumber of casesAge groupsSignificant associationCancerDiseaseLarge hospitalsWomenRiskHospitalUterusBreast